Org.2766 improves functional and electrophysiological aspects of regenerating sciatic nerve in the rat - PubMed (original) (raw)
Org.2766 improves functional and electrophysiological aspects of regenerating sciatic nerve in the rat
P De Koning et al. Peptides. 1987 May-Jun.
Abstract
The beneficial effect of short-term (8 days) melanocortin therapy on regenerating peripheral nerves is demonstrated using functional and electrophysiological tests. Following a crush lesion of the rat sciatic nerve, recovery of sensory function is monitored by assessing the responsiveness of the rat to a small electric current applied to the footsole. Recovery of motor function is assessed by means of an analysis of walking patterns. Normalization of the walking pattern reflects reinnervation of different muscle groups. The motor and H-reflex related sensory nerve conduction velocity of the regenerated nerves are longitudinally investigated in the same rats in which the recovery of motor and sensory function had been assessed previously. Functional tests show an enhanced recovery under melanocortin therapy, but in the end both saline- and melanocortin-treated rats show 100% recovery. However, when compared to the contralateral sciatic nerve, in the peptide-treated animals motor nerve conduction in the regenerated nerves has fully recovered after about 90 days following the crush lesion and the sensory conduction after about 120 days, whereas in the saline-treated rats a deficit of 20-40% in both motor and sensory conduction remains. This difference is observed even 214 days following crush.
Similar articles
- Morphological and electrophysiological study of the effects of cisplatin and ORG.2766 on rat spinal ganglion neurons.
Müller LJ, Gerritsen van der Hoop R, Moorer-van Delft CM, Gispen WH, Roubos EW. Müller LJ, et al. Cancer Res. 1990 Apr 15;50(8):2437-42. Cancer Res. 1990. PMID: 2156619 - Exercise training improves functional recovery and motor nerve conduction velocity after sciatic nerve crush lesion in the rat.
van Meeteren NL, Brakkee JH, Hamers FP, Helders PJ, Gispen WH. van Meeteren NL, et al. Arch Phys Med Rehabil. 1997 Jan;78(1):70-7. doi: 10.1016/s0003-9993(97)90013-7. Arch Phys Med Rehabil. 1997. PMID: 9014961 Review. - Putative neurotrophic factors and functional recovery from peripheral nerve damage in the rat.
Van der Zee CE, Brakkee JH, Gispen WH. Van der Zee CE, et al. Br J Pharmacol. 1991 May;103(1):1041-6. doi: 10.1111/j.1476-5381.1991.tb12297.x. Br J Pharmacol. 1991. PMID: 1678980 Free PMC article. - A new approach for the evaluation of recovery after peripheral nerve damage.
van der Hoop RG, Brakkee JH, Kapelle A, Samson M, de Koning P, Gispen WH. van der Hoop RG, et al. J Neurosci Methods. 1988 Dec;26(2):111-6. doi: 10.1016/0165-0270(88)90159-8. J Neurosci Methods. 1988. PMID: 2851075 - Melanocortins as factors in somatic neuromuscular growth and regrowth.
Strand FL, Williams KA, Alves SE, Antonawich FJ, Lee TS, Lee SJ, Kume J, Zuccarelli LA. Strand FL, et al. Pharmacol Ther. 1994 Apr-May;62(1-2):1-27. doi: 10.1016/0163-7258(94)90002-7. Pharmacol Ther. 1994. PMID: 7991638 Review.
Cited by
- Melanocortins applied intravitreally delay retinal dystrophy in Royal College of Surgeons rats.
Naveh N. Naveh N. Graefes Arch Clin Exp Ophthalmol. 2003 Dec;241(12):1044-50. doi: 10.1007/s00417-003-0781-y. Epub 2003 Oct 30. Graefes Arch Clin Exp Ophthalmol. 2003. PMID: 14586589 - Reversal of experimental diabetic neuropathy by VEGF gene transfer.
Schratzberger P, Walter DH, Rittig K, Bahlmann FH, Pola R, Curry C, Silver M, Krainin JG, Weinberg DH, Ropper AH, Isner JM. Schratzberger P, et al. J Clin Invest. 2001 May;107(9):1083-92. doi: 10.1172/JCI12188. J Clin Invest. 2001. PMID: 11342572 Free PMC article. - Lack of neuroprotection by an ACTH (4-9) analogue. A randomized trial in patients treated with vincristine for Hodgkin's or non-Hodgkin's lymphoma.
Koeppen S, Verstappen CC, Körte R, Scheulen ME, Strumberg D, Postma TJ, Heimans JJ, Huijgens PC, Kiburg B, Renzing-Köhler K, Diener HC. Koeppen S, et al. J Cancer Res Clin Oncol. 2004 Mar;130(3):153-60. doi: 10.1007/s00432-003-0524-9. Epub 2004 Jan 16. J Cancer Res Clin Oncol. 2004. PMID: 14727106 Clinical Trial. - FK506 and the role of immunophilins in nerve regeneration.
Gold BG. Gold BG. Mol Neurobiol. 1997 Dec;15(3):285-306. doi: 10.1007/BF02740664. Mol Neurobiol. 1997. PMID: 9457703 Review. - Treatment of diabetic polyneuropathy with the neurotrophic peptide ORG 2766.
Valk GD, Kappelle AC, Tjon-A-Tsien AM, Bravenboer B, Bakker K, Michels RP, Groenhout CM, Bertelsmann FW. Valk GD, et al. J Neurol. 1996 Mar;243(3):257-63. doi: 10.1007/BF00868523. J Neurol. 1996. PMID: 8936356 Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources